Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.

OBJECTIVE To determine the cytotoxicity of natural killer (NK) cells and the level of differentiation of hematopoietic stem cells (HSCs) into NK cells in systemic lupus erythematosus (SLE). METHODS Patients with SLE (n=108), rheumatoid arthritis (RA; n=90), Behçet's disease (n=39), or ankylosing spondylitis (n=41) and healthy control subjects (n=173) were enrolled in the study. NK cell levels, NK cell cytotoxicities, and lymphokine-activated killer (LAK) activities against K562 cells were measured by flow cytometry. Gene expression was assessed by reverse transcription-polymerase chain reaction. NK cells were differentiated from peripheral blood and bone marrow HSCs in vitro. RESULTS Percentages and absolute numbers of NK cells, cytotoxicities, and LAK activities were significantly lower in the peripheral blood of SLE and RA patients than in that of healthy controls. In particular, this NK cell deficiency was more prominent in patients with lupus nephritis and those with thrombocytopenia. Notably, purified NK cells derived from SLE patients, but not RA patients, were found to have lower cytotoxicities and LAK activities than those from healthy controls. This defect of NK cells in SLE patients was found to be related to lower numbers of NK precursors and to the down-regulation of perforin and granzyme in NK cells. The proliferative capacity of HSCs, the percentages of NK cells differentiated from HSCs, and NK cell cytotoxicities were significantly lower in SLE patients. CONCLUSION In SLE patients, circulating levels of NK cells were diminished and their cytotoxicities were impaired. Furthermore, the differentiation of HSCs into NK cells was found to be defective. These abnormalities possibly contribute to immune system dysregulation in SLE.

[1]  N. Huntington,et al.  Developmental pathways that generate natural-killer-cell diversity in mice and humans , 2007, Nature Reviews Immunology.

[2]  M. Verhaar,et al.  Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus , 2007, Annals of the rheumatic diseases.

[3]  R. Oostendorp,et al.  Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. , 2006, Blood.

[4]  Sangsoo Kim,et al.  Stage-dependent gene expression profiles during natural killer cell development. , 2005, Genomics.

[5]  D. Isenberg,et al.  Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients , 2005, Clinical and experimental immunology.

[6]  G. Obermoser,et al.  Apoptosis of CD34 cells after incubation with sera of leukopenic patients with systemic lupus erythematosus , 2003, Lupus.

[7]  M. Caligiuri,et al.  What does it take to make a natural killer? , 2003, Nature Reviews Immunology.

[8]  J. Axford,et al.  Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus , 2001, British journal of haematology.

[9]  S. Yamasaki,et al.  A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases. , 2001, Arthritis and rheumatism.

[10]  H. Gaines,et al.  A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry. , 2000, Journal of immunological methods.

[11]  D. Chaplin,et al.  Requirement for membrane lymphotoxin in natural killer cell development. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Raulet.  Development and tolerance of natural killer cells. , 1999, Current opinion in immunology.

[13]  M. Caligiuri,et al.  Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15 , 1998 .

[14]  P. Lydyard,et al.  Lack of NK cells in lupus patients with renal involvement , 1997, Lupus.

[15]  M. Hirokawa,et al.  The immunoregulatory effects of NK cells: the role of TGF-beta and implications for autoimmunity. , 1997, Immunology today.

[16]  R. Kimberly,et al.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. , 1997, The Journal of clinical investigation.

[17]  T. Mak,et al.  Abnormal Development of Intestinal Intraepithelial Lymphocytes and Peripheral Natural Killer Cells in Mice Lacking the IL-2 Receptor β Chain , 1997, The Journal of experimental medicine.

[18]  S. Jawahar,et al.  Natural killer (NK) cell deficiency associated with an epitope‐deficient Fc receptor type IIIA (CD16‐II) , 1996, Clinical and experimental immunology.

[19]  J. O’Shea,et al.  Receptor-induced death in human natural killer cells: involvement of CD16 , 1995, The Journal of experimental medicine.

[20]  M. Caligiuri,et al.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor , 1994, The Journal of experimental medicine.

[21]  D. Cosman,et al.  Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. , 1994, EMBO Journal.

[22]  T. Huizinga,et al.  Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells. , 1993, Journal of immunology.

[23]  D. Isenberg,et al.  Lymphocyte Subsets in a Large Cohort of Patients with Systemic Lupus Erythematosus , 1993, Lupus.

[24]  K. Takeda,et al.  The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms , 1993, The Journal of experimental medicine.

[25]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[26]  C. Bridts,et al.  Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes. , 1990, Annals of the rheumatic diseases.

[27]  International Study Group for Behçet's Disease,et al.  Criteria for diagnosis of Behcet's disease , 1990, The Lancet.

[28]  M. Caligiuri,et al.  Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors , 1990, The Journal of experimental medicine.

[29]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[30]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[31]  K. Sugamura,et al.  Activation of natural killer cells via the p75 interleukin 2 receptor , 1989, The Journal of experimental medicine.

[32]  H. Hara,et al.  Decreased expression of interleukin-2 binding molecules (p70/75) in T cells from patients with systemic lupus erythematosus. , 1989, Arthritis and rheumatism.

[33]  R. González-Amaro,et al.  Natural killer cell activity in the systemic connective tissue diseases. , 1988, The Journal of rheumatology.

[34]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[35]  W. Leonard,et al.  The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. , 1987, Science.

[36]  J. Yodoi,et al.  Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus. , 1987, Journal of immunology.

[37]  W. Seaman,et al.  Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity. , 1987, Journal of immunology.

[38]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[39]  C. Froelich,et al.  Abnormal interferon modulation of natural cytotoxicity in systemic lupus erythematosus. Relation to suppressive serum factors. , 1983, Arthritis and rheumatism.

[40]  C. Froelich,et al.  Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors. , 1983, Clinical and experimental immunology.

[41]  A. Bankhurst,et al.  Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers. , 1983, The Journal of clinical investigation.

[42]  C. Balch,et al.  Natural Killer Cells in Systemic Lupus Erythematosus , 1983 .

[43]  R. Panush,et al.  Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event. , 1982, Journal of immunology.

[44]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[45]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.

[46]  M. Goto,et al.  Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody. , 1980, Arthritis and rheumatism.

[47]  A. Silman,et al.  [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.

[48]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[49]  K. Koike,et al.  A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. , 1996, The Journal of rheumatology.

[50]  渋谷 彰.  Lymphokine requirement for the generation of natural killer cells from CD34[+] hematopoietic progenitor cells , 1996 .

[51]  C. Balch,et al.  Natural killer cells in systemic lupus erythematosus. Abnormal numbers and functional immaturity of HNK-1+ cells. , 1983, Arthritis and rheumatism.

[52]  T. Hoffman.  Natural killer function in systemic lupus erythematosus , 1980 .